Terpenoid ID | TKC112826 | |
Cell line | 0 | |
Protein target | 12 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 14 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC112826 | HT-29 | HT 29; HT29 | 25700.0 | nM | IC50 | C4349 | |
TKC112826 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 75000.0 | nM | IC50 | ||
TKC112826 | C6 | C-6; C 6; RGC-6; RGC6; RGc6 | 20000.0 | nM | IC50 | C64069 | |
TKC112826 | U-937 | U937; U 937 | 2.0 | % | Activity | C8263 | Orphanet_514 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC112826 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 16360 | nM | Potency |
TKC112826 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 91 | % | Inhibition |
TKC112826 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 97 | % | Inhibition |
TKC112826 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 100000 | nM | Potency |
TKC112826 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 33588 | nM | Potency |
TKC112826 | Q9UNA4 | DNA polymerase iota | POLI | 89125 | nM | Potency |
TKC112826 | O75496 | Geminin | GMNN | 146 | nM | Potency |
TKC112826 | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | USP1 | 10000 | nM | Potency |
TKC112826 | O00255 | Menin | MEN1 | 3981 | nM | Potency |
TKC112826 | P02791 | Ferritin light chain | FTL | 39811 | nM | Potency |
TKC112826 | P16050 | Polyunsaturated fatty acid lipoxygenase ALOX15 | ALOX15 | 31623 | nM | Potency |
TKC112826 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | USP2 | 3981 | nM | Potency |
TKC112826 | P35398 | Nuclear receptor ROR-alpha | RORA | 12 | nM | Ki |
TKC112826 | Q9UHC9 | NPC1-like intracellular cholesterol transporter 1 | NPC1L1 | 8700 | nM | EC50 |
TKC112826 | Q9Y6A2 | Cholesterol 24-hydroxylase | CYP46A1 | 53 | % | Activity |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O94782 | UBP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75604 | UBP2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P35398 | RORA_HUMAN | Liver cancer [ICD-11: 2C12] |
P35398 | RORA_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q9UHC9 | NPCL1_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q9Y6A2 | CP46A_HUMAN | Acidosis [ICD-11: 5C73] |
Q9Y6A2 | CP46A_HUMAN | Epilepsy/seizure [ICD-11: 8A61-8A6Z] |
Q9Y6A2 | CP46A_HUMAN | Epileptic encephalopathy [ICD-11: 8A62] |
Q9Y6A2 | CP46A_HUMAN | Phakomatoses/hamartoneoplastic syndrome [ICD-11: LD2D] |
Q9Y6A2 | CP46A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |